Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement

CELL DISCOVERY

SPRINGERNATURE

1. Chinese Academy of Sciences [XDB29040300]
2. Chinese Ministry of Science and Technology [2020YFC0845900]
3. Shanghai Science and Technology Committee
4. Project of Novel Coronavirus Research from Fudan University